Francesco Caroli Selected Research

Neurocutaneous Syndromes (Phakomatoses)

3/2023

Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of RNF213.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Caroli Research Topics

Disease

3	Fever (Fevers) 01/2020 - 03/2005
3	Alexander Disease (Alexander's Disease) 06/2011 - 01/2008
2	Inflammation (Inflammations) 08/2020 - 12/2014
2	Neoplasms (Cancer) 01/2019 - 10/2018
1	Neurocutaneous Syndromes (Phakomatoses) 03/2023
1	Moyamoya Disease (Moya-Moya Disease) 03/2023
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 03/2023
1	Muscle Weakness 01/2022
1	Speech Disorders (Cluttering) 01/2022
1	Deglutition Disorders (Dysphagia) 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Carcinoma (Carcinomatosis) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Acne Vulgaris 12/2014
1	Pyoderma Gangrenosum 12/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2014
1	Hidradenitis Suppurativa 12/2014
1	Cryopyrin-Associated Periodic Syndromes 09/2013
1	Mevalonate Kinase Deficiency 11/2012
1	Skin Diseases (Skin Disease) 01/2012
1	autosomal dominant familial Periodic fever 07/2011
1	Gliosis 11/2010
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 05/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2008
1	Holoprosencephaly (Arhinencephaly) 03/2003
1	beta-Thalassemia (Cooley's Anemia) 12/2002

Drug/Important Bio-Agent (IBA)

3	Glial Fibrillary Acidic ProteinIBA 06/2011 - 01/2008
2	Colchicine FDA LinkGeneric 01/2020 - 01/2020
2	AntigensIBA 01/2019 - 10/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018 - 07/2011
2	CytokinesIBA 12/2014 - 11/2010
2	EnzymesIBA 11/2012 - 03/2005
2	mevalonate kinaseIBA 11/2012 - 03/2005
1	Neurofibromin 1 (Neurofibromin)IBA 03/2023
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2020
1	SteroidsIBA 01/2020
1	CD3 ComplexIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Bispecific AntibodiesIBA 01/2019
1	Monoclonal AntibodiesIBA 10/2018
1	LigandsIBA 10/2018
1	AutoantibodiesIBA 12/2014
1	Fas Ligand Protein (Fas Ligand)IBA 12/2014
1	CD40 Ligand (CD40L)IBA 12/2014
1	tocilizumab (atlizumab)FDA Link 09/2013
1	Hormones (Hormone)IBA 11/2010
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2010
1	Transcription Factors (Transcription Factor)IBA 11/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2010
1	Interleukin-18 (Interleukin 18)IBA 05/2008
1	Interleukin-1 (Interleukin 1)IBA 05/2008
1	Immunoglobulin D (IgD)IBA 03/2005
1	Nonsense Codon (Nonsense Mutation)IBA 03/2003
1	Factor VII (Proconvertin)IBA 12/2002
1	DNA (Deoxyribonucleic Acid)IBA 12/2002

Therapy/Procedure

1	Noninvasive Ventilation 01/2022
1	Therapeutics 01/2022
1	Immunotherapy 01/2019
1	Bariatric Surgery 01/2012